中国组织工程研究 ›› 2015, Vol. 19 ›› Issue (23): 3768-3772.doi: 10.3969/j.issn.2095-4344.2015.23.027

• 干细胞综述 stem cell review • 上一篇    

重编程细胞的命运

阮光萍,姚  翔,刘菊芬,胡媛媛,王金祥,何  洁,赵  晶,潘兴华   

  1. 解放军成都军区昆明总医院细胞生物治疗中心,干细胞与免疫细胞生物医药技术国家地方联合工程实验室,云南省细胞治疗技术转化医学重点实验室,云南省昆明市  650032
  • 出版日期:2015-06-04 发布日期:2015-06-04
  • 通讯作者: 潘兴华,博士,主任医师,解放军成都军区昆明总医院细胞生物治疗中心,干细胞与免疫细胞生物医药技术国家地方联合工程实验室,云南省细胞治疗技术转化医学重点实验室,云南省昆明市 650032
  • 作者简介:阮光萍,女,1974年生,云南省昆明市人,汉族,2007年南方医科大学毕业,博士,副主任医师,主要从事干细胞基础与临床研究。
  • 基金资助:

    国家支撑计划(2014BAI01B01);云南省科技计划项目(2013CA005)资助课题

Fate of reprogramming cells

Ruan Guang-ping, Yao Xiang, Liu Ju-fen, Hu Yuan-yuan, Wang Jin-xiang, He Jie, Zhao Jing, Pan Xing-hua   

  1. The Cell Biological Therapy Center, Kunming General Hospital of Chengdu Military Command, State & Regions Integrated Engineering Laboratory of Stem Cells and Immune Cells Biomedical Techniques, Yunnan Provincial Key Laboratory
  • Online:2015-06-04 Published:2015-06-04
  • Contact: Pan Xing-hua, M.D., Chief physician, the Cell Biological Therapy Center, Kunming General Hospital of Chengdu Military Command, State & Regions Integrated Engineering Laboratory of Stem Cells and Immune Cells Biomedical Techniques, Yunnan Provincial Key Laboratory of Cell Therapy Technology Transfer Medicine, Kunming 650032, Yunnan Province, China
  • About author:Ruan Guang-ping, M.D., Associate chief physician, the Cell Biological Therapy Center, Kunming General Hospital of Chengdu Military Command, State & Regions Integrated Engineering Laboratory of Stem Cells and Immune Cells Biomedical Techniques, Yunnan Provincial Key Laboratory of Cell Therapy Technology Transfer Medicine, Kunming 650032, Yunnan Province, China
  • Supported by:

    the National Support Program of China, No. 2014BAI01B01; Yunnan Provincial Science and Technology Project, No. 2013CA005

摘要:

背景:体细胞重新编程技术也称细胞重组技术,使已经完成分化的体细胞回到原始的全能性或多能性状态,并可以重新分化成与原来不一样的细胞。通过重编程技术可以获得患者特异性诱导多能干细胞和疾病特异性诱导多能干细胞,显著减少了免疫排斥反应。
目的:探讨关于直接重编程到特定系的方法,总结参与重编程的分子机制。
方法:以“重编程”为中文检索词,“reprogramming”为英文检索词,应用计算机检索维普(VIP)期刊全文数据库、万方全文数据库、中国知网全文数据库、PubMed 数据库、Springer 数据库1958 年1 月至2015年4月有关细胞重编程技术的文献,排除与研究目的无关及重复性研究,保留40篇文献进一步分析。
结果与结论:当前重编程的步骤效率很低,在特定群只有相对少量的细胞能进行重编程,重编程的完整性和程度也有待证实。直接重编程成体、定系的细胞从一种细胞到另一种细胞一直是发育生物学很难达到的目标。最近的研究证明分化的细胞强制表达特异转录因子能促进细胞分化。这些发现使再生医学领域有了重大进展,可以提供替代细胞治疗各种再生紊乱。目前,基本的分子机制需要进一步阐明,在直接重编程被应用于临床之前还有许多问题需要解决。

中国组织工程研究杂志出版内容重点:干细胞;骨髓干细胞;造血干细胞;脂肪干细胞;肿瘤干细胞;胚胎干细胞;脐带脐血干细胞;干细胞诱导;干细胞分化;组织工程

关键词: 干细胞, 分化, 重编程, 特异转录因子, 再生医学, 多能性

Abstract:

BACKGROUND: Somatic cell reprogramming technology, also known as recombinant technology, has completed differentiated somatic cells back to the original totipotent or pluripotent state, and can be re-differentiated into cells different from original ones. Re-programming techniques are able to harvest specifically induced pluripotent stem cells and disease-specific induced pluripotent stem cells from patients, which can significantly reduce the immune rejection.
OBJECTIVE: To explore the method from direct reprogramming to specific cell lines and to conclude the
molecular mechanisms underlying reprogramming.
METHODS: A computer-based search of VIP, Wanfang, CNKI, PubMed and Springer databases was performed for articles related to cell reprogramming techniques published from January 1958 to April 2015 using the keywords of “reprogramming” in Chinese and English, respectively. After elimination of unrelated and repetitive studies, 40 articles were retained for further analysis.
RESULTS AND CONCLUSION: Current reprogramming steps are inefficient that in the specific group only a relatively small number of cells can be reprogrammed, and the extent and integrity of reprogramming are questionable. Direct reprogramming of adult cells and specific cell lines that are changed to another line is always a difficulty in developmental biology. Recent studies have proved that differentiated cells can forcibly express specific transcription factor to improve cell differentiation. This discovery is a great progress in regenerative medicine that cell replacement therapy can be provided for renewable disorders. At present, the basic molecular mechanisms require further clarification, and there are many problems to be solved before the direct reprogramming is used clinically.

中国组织工程研究杂志出版内容重点:干细胞;骨髓干细胞;造血干细胞;脂肪干细胞;肿瘤干细胞;胚胎干细胞;脐带脐血干细胞;干细胞诱导;干细胞分化;组织工程

Key words: Nuclear Reprogramming, Transcription Factor, Induced Pluripotent Stem Cells

中图分类号: